[ASAP] Positron-Emission Tomography of HER2-Positive Breast Cancer Xenografts in Mice with < sup > 89 < /sup > Zr-Labeled Trastuzumab-DM1: A Comparison with < sup > 89 < /sup > Zr-Labeled Trastuzumab
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.8b00392
Source: Molecular Pharmaceutics - Category: Drugs & Pharmacology Authors: Noor Al-saden, Karen Lam, Conrad Chan, Raymond M. Reilly Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Drugs & Pharmacology | HER2 | Herceptin | PET Scan